Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have a body mass index (BMI) between 27 to 45 kilograms per meter squared (kg/m²), inclusive at screening
For nondiabetic subjects: as determined by medical history, physical examination, and safety assessments at screening
For participants with a confirmed type 2 diabetes diagnosis: The condition must be managed either by diet and exercise alone or on a stable dose of metformin for the past 3 months
Willing and agreeable to commit to the duration of the study and undergo study procedures as instructed by the clinic staff
You may not be if
Have undergone gastric bypass or bariatric surgery
Have received prescription drugs or over the counter drugs that promote weight loss in the past 6 months prior to screening
For participants with a confirmed type 2 diabetes diagnosis: Have experienced more than 1 episode of severe low blood sugar that require emergency treatment, hospitalization or third parties to administer rescue treatment, in the past 6 months
Have any lifetime history of a suicide attempt
Have other medical conditions or medical history that make participation in the study unsafe or which may interfere in the interpretation of the results of the study
Unwilling to comply with smoking and alcohol restrictions during the study
Clareo Health | A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide
